FDA panel unanimously votes in favor of RSV antibody treatment for infants ...Middle East

The Food and Drug Administration's (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving an RSV treatment for infants, bringing the product closer to approval following the overwhelming surge in RSV cases that were seen last year in young children. All 21 members of the FDA's Antimicrobial Drugs Advisory Committee (AMDAC) who were present for the meeting voted "yes" on the question of whether the drug nirsevimab had an overall benefit-risk assessment that was favorable for preventing RSV infections. Mary Anne Jackson, dean of the University of Missouri-Kansas City School of Medicine, said she voted yes because there is a need for such a medicine a

Hence then, the article about fda panel unanimously votes in favor of rsv antibody treatment for infants was published today ( Friday 09/06/2023 - 01:40 AM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA panel unanimously votes in favor of RSV antibody treatment for infants )

Also on site :

• Vue Cinema Chain Halts Liquidation Threat From Coca-Cola Bottling Giant After Settling Unpaid Bill
• 45 Best Nonfiction Books of All Time, According to Librarians
• Amazon's Bestselling Fleece-Lined Thermal Base Layer Set Is Just $35 Ahead of a Major Winter Storm